Skip to main content
. 2022 Nov 14;17(11):e0277641. doi: 10.1371/journal.pone.0277641

Table 1. Patient baseline characteristics at the time of intensive care unit admission.

All (n = 66)
Demographics
Age, years 67 (53–71)
Sex, male 47 (71.2%)
Body mass index, kg/m2 26.1 (23.4–29.0)
Race
Asian 56 (84.8%)
Latino 10 (15.2%)
Scoring at ICU admission
APACHE II 15 (9–21)
SOFA 4 (2–7)
Hospital
Gunma University Hospital 24 (36%)
Japanese Red Cross Maebashi Hospital 23 (35%)
Subaru Health Insurance Society Ota Memorial Hospital 19 (29%)
Comorbidities
Cancer 3 (4.6%)
Diabetes mellitus 29 (43.9%)
Obesity 12 (18.2%)
Hypertension 37 (56.1%)
Chronic heart failure 4 (6.1%)
Angina/previous myocardial infarction 7 (10.6%)
Chronic kidney disease 13 (19.7%)
Dialysis 7 (10.6%)
Laboratory data at admission
White blood cells, ×109/mL 7650 (4950–9925)
Lymphocytes, ×106/mL 680 (480–960)
Platelet count, ×103/mL 174.0 (125.3–228.8)
Lactate dehydrogenase, U/L 347 (270–466)
Creatine kinase, U/L 86 (49–170)
Aspartate transaminase, U/L 37 (28–54)
Alanine transaminase, U/L 27 (17–40)
Total bilirubin, mg/dL 0.6 (0.4–0.8)
Blood urea nitrogen, mg/dL 18 (13–32)
Serum creatinine, mg/dL 0.79 (0.62–1.27)
eGFR, mL/min/m2 70.0(42.0–88.6)
C-reactive protein, mg/dL 7.52 (3.83–13.46)
PT-INR 1.04 (0.99–1.11)
APTT, sec 33.5 (30.2–38.2)
Fibrinogen, mg/dL 546 (452–616)
Antithrombin activity †, % 82.5 (75.1–96.0)
D-dimer, μg/mL 1.5 (1.0–2.4)
Heparin usage before admission 5 (7.5%)

Data are presented as the median (interquartile range) or number (%). APACHE II, Acute Physiology and Chronic Health Evaluation II score; SOFA, Sequential Organ Failure Assessment score; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate; PT-INR, the international normalized ratio of prothrombin time; APTT, activated partial thromboplastin time. Obesity was defined as a body mass index of over 30 kg/m2. † Four patients in the no-mechanical ventilation group lacked data on antithrombin activity.